Influence of fentanyl and morphine on intestinal circulation.
The influence of fentanyl and morphine on the intestinal circulation was evaluated in an isolated loop preparation in 37 dogs anesthetized with pentobarbital intravenously. Selected intestinal segments were pumped with aortic blood at a constant pressure of 100 mm Hg. A mixture of 86Rb and 9-micron spheres labeled with 141Ce was injected into the arterial cannula supplying the intestinal loop, while mesenteric venous blood was collected for activity counting. A strong correlation was found between the clearances of rubidium and microspheres (r = 0.97, P less than 0.0001), suggesting that the shunting of 9-micron spheres through the intestines reflects the shunting of blood through nonnutritive vessels. Intravenous fentanyl decreased oxygen uptake (O2up), and vascular resistance (VR), and increased blood flow (BF), rubidium and microsphere clearances (Cl-Rb, Cl-Sph, respectively), and permeability--surface area product (PS) in a dose-related fashion. Intravenous morphine in a dose of 1 mg X kg-1 increased Cl-Rb (nutritive BF) without changes in total (nutritive and nonnutritive) BF. This increase in nutritive BF is probably related to morphine-induced histamine release. Morphine in a dose of 5 mg X kg-1 was accompanied by vasoconstriction that was completely abolished by alpha-adrenoceptor blockade. The data suggest that morphine-induced intestinal vasoconstriction is mediated via a release of epinephrine, apparently from the adrenal medulla. It is concluded that changes in the intestinal circulation during anesthesia with narcotics might play a certain role in the cardiovascular homeostasis during anesthesia and surgery. An increase in oxygen content in portal venous blood, resulting from a decrease in intestinal oxygen uptake, should facilitate hepatic oxygenation.
D000818:Animals; D001784:Blood Gas Analysis; D002588:Cesium Radioisotopes; D002927:Cimetidine / Q000494:pharmacology; D004285:Dogs; D004347:Drug Interactions; D005283:Fentanyl / Q000494:pharmacology*; D006863:Hydrogen-Ion Concentration; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000098:blood supply* / Q000187:drug effects; D008863:Microspheres; D009020:Morphine / Q000494:pharmacology*; D010101:Oxygen Consumption; D010424:Pentobarbital / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011398:Promethazine / Q000494:pharmacology; D011868:Radioisotopes; D012039:Regional Blood Flow / Q000187:drug effects; D012413:Rubidium; D014655:Vascular Resistance / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects
D002588:Cesium Radioisotopes; D011868:Radioisotopes; D009020:Morphine; D002927:Cimetidine; D011398:Promethazine; D010424:Pentobarbital; D012413:Rubidium; D005283:Fentanyl; D010646:Phentolamine